» Articles » PMID: 39596218

Radial Data Visualization-Based Step-by-Step Eliminative Algorithm to Predict Colorectal Cancer Patients' Response to FOLFOX Therapy

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2024 Nov 27
PMID 39596218
Authors
Affiliations
Soon will be listed here.
Abstract

Application of the FOLFOX scheme to colorectal cancer (CRC) patients often results in the development of chemo-resistance, leading to therapy failure. This study aimed to develop a functional and easy-to-use algorithm to predict patients' response to FOLFOX treatment. Transcriptomic data of CRC patient's samples treated with FOLFOX were downloaded from the Gene Expression Omnibus database (GSE83129, GSE28702, GSE69657, GSE19860 and GSE41568). Comparing the expression of top up- and downregulated genes in FOLFOX responder and non-responder patients' groups, we selected 30 potential markers that were used to create a step-by-step eliminative procedure based on modified radial data visualization, which depicts the interplay between the expression level of chosen attributes (genes) to locate data points in low-dimensional space. Our analysis proved that FOLFOX-resistant CRC samples are predominantly characterized by upregulated expression levels of and and downregulated Additionally, the procedure developed based on expression levels of , , , , , , , , , , , , and proved to be capable in predicting FOLFOX therapy response. In conclusion, our approach can give a unique insight into clinical decision-making regarding therapy scheme administration, potentially increasing patients' survival and, consequently, medical futility due to incorrect therapy application.

References
1.
Noordzij I, Curvers W, Schoon E . Endoscopic resection for early esophageal carcinoma. J Thorac Dis. 2019; 11(Suppl 5):S713-S722. PMC: 6503291. DOI: 10.21037/jtd.2019.03.19. View

2.
Chen K, Ye C, Gao Z, Hu J, Chen C, Xiao R . Immune infiltration patterns and identification of new diagnostic biomarkers GDF10, NCKAP5, and RTKN2 in non-small cell lung cancer. Transl Oncol. 2023; 29:101618. PMC: 9843486. DOI: 10.1016/j.tranon.2023.101618. View

3.
Vatandoust S, Price T, Karapetis C . Colorectal cancer: Metastases to a single organ. World J Gastroenterol. 2015; 21(41):11767-76. PMC: 4631975. DOI: 10.3748/wjg.v21.i41.11767. View

4.
Qi F, Yang Y, Zhang H, Chen H . Long non-coding RNAs: Key regulators in oxaliplatin resistance of colorectal cancer. Biomed Pharmacother. 2020; 128:110329. DOI: 10.1016/j.biopha.2020.110329. View

5.
Zhao L, Yu Q, Gao C, Xiang J, Zheng B, Feng Y . Studies of the Efficacy of Low-Dose Apatinib Monotherapy as Third-Line Treatment in Patients with Metastatic Colorectal Cancer and Apatinib's Novel Anticancer Effect by Inhibiting Tumor-Derived Exosome Secretion. Cancers (Basel). 2022; 14(10). PMC: 9139438. DOI: 10.3390/cancers14102492. View